Detalles de la búsqueda
1.
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34+ Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability.
Stem Cells
; 37(10): 1357-1368, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31184411
2.
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
Br J Haematol
; 185(3): 480-491, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30793290
3.
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group.
Br J Haematol
; 178(5): 699-708, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28782811
4.
Long-term complication in follicular lymphoma: assessing the risk of secondary neoplasm in 242 patients treated or not with 90-yttrium-ibritumomab-tiuxetan.
Eur J Haematol
; 97(6): 576-582, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27157440
5.
Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?
Front Bioeng Biotechnol
; 7: 308, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31781552
Resultados
1 -
5
de 5
1
Próxima >
>>